Effect of HIV-1 Tat on Secretion of TNF-α and IL-1β by U87 Cells in AIDS Patients with or without AIDS Dementia Complex

Biomedical and Environmental Sciences

Volumn 27, Issue 2, 2014, Pages 111-117

  Zhao, Li ^a   Pu, Shuang Shuang ^b   Gao, Wen Hua ^c   Chi, Yuan Yuan ^a   Wen, Hong Ling ^a   Wang, Zhi Yu ^a   Song, Yan Yan ^a   Yu, Xue Jie ^a,d  

^a SHANDONG UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

HIV 1 tat gene AIDS dementia complex Cytokines TNF IL 1 Neurotoxicity

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BASAL GANGLION; BIOSYNTHESIS; CASE REPORT; GENE EXPRESSION REGULATION; GENETICS; GLIA; HIV ASSOCIATED DEMENTIA; HIV-1 TAT GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IL-1Β; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NEUROTOXICITY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; REGULATOR GENE; SECRETION (PROCESS); SPLEEN; TNF-Α; TUMOR CELL LINE; VIROLOGY;

AIDS DEMENTIA COMPLEX; CYTOKINES; HIV-1 TAT GENE; IL-1Β; NEUROTOXICITY; TNF-Α;

ADULT; AIDS DEMENTIA COMPLEX; AMINO ACID SEQUENCE; BASAL GANGLIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; GENES, TAT; HIV-1; HUMANS; INTERLEUKIN-1BETA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEUROGLIA; SPLEEN; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896992160     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/bes2014.024     Document Type: Article

References (27)

1. C Hogan, E Wilkins Neurological complications in HIV Clin Med 11 2011 571 575
2. R Cheung, V Ravyn, LS Wang et al. Signaling mechanism of HIV-1 gp120 and virion-Induced IL-1β release in primary human macrophages J Immunol 180 2008 6675 6684
3. H Peng, N Erdmann, N Whitney HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1β Glia 54 2006 619 629
4. GJ Dore, A McDonald, Y Li et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy AIDS 7 2003 1539 1545
5. V Tozzi, P Balestra, P Lorenzini et al. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort J Neurovirol 11 2005 265 273
6. NZ Mothobi, BJ Brew Neurocognitive dysfunction in the highly active antiretroviral therapy era Curr Opin Infect Dis 25 2012 4 9
7. SS Spudich, BM Ances Central nervous system complications of HIV infection Top Antivir Med 19 2011 48 57
8. JC McArthur, BJ Brew, A Nath Neurological complications of HIV infection Lancet Neurol 4 2005 543 555
9. L Agrawal, JP Louboutin, BA Reyes et al. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes Neurobiol Dis 45 2012 657 670
10. CB Pocernich, R Sultana, H Mohmmad-Abdul HIV-dementia, Tat-induced oxidativestress, and antioxidant therapeutic considerations Brain Research Reviews 50 2005 14 26
11. AM Blamire, DC Anthony, B Rajagopalan et al. Interleukin-1 beta-induced changes in blood-brain barrier permeability, apparent diffusion coeffiient, and cerebral blood volume in the rat brain: a magnetic resonance study J Neurosci 20 2000 8153 8159
12. K Devadas, NJ Hardegen, LM Wahl et al. Mechanisms for macrophage-mediated HIV-1 induction J Immunol 173 2004 6735 6744
13. R Garg, C Barat, M Ouellet et al. Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-alpha PLoS Negl Trop Dis 3 2009 e441
14. J Cao, JI Viholainen, C Dart et al. The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death J Cell Biol 168 2005 117 126
15. M Guido van, P Christopher Human immunodeficiency virus type 1 genetic diversity in the nervous system: Evolutionary epiphenomenon or disease determinant? J Neurovirol 11 2005 107 128
16. A De Luca, BC Ciancio, D Larussa et al. Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals Neurology 59 2002 342 347
17. KV Khanna, XF Yu, DH Ford et al. Differences among HIV-1 Variants in their ability to elicit secretion of TNF-alpha J Immunol 164 2000 1408 1415
18. JE King, EA Eugenin, CM Buckner et al. HIV tat and neurotoxicity Microbes and Infection 8 2006 1347 1357
19. E Kim, M Sheng PDZ domain proteins of synapses Nat Rev Neurosci 5 2004 771 781
20. GR Campbell, EP Loret What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology 6 2009 1 13
21. SM Ju, HY Song, JA Lee et al. Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-κB dependent pathway in human astrocytes Exp Mol Med 41 2009 86 93
22. G van Marle, C Power Human immunodeficiency virus type 1 genetic diversity in the nervous system: Evolutionary epiphenomenon or disease determinant? J Neurovirol 11 2005 107 128
23. Z Sui, LF Sniderhan, G Schifitto et al. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia J Immunol 178 2007 3226 3236
24. T Nolting, A Lindecke, HP Hartung et al. Cytokine levels in CSF and neuropsychological performance in HIV patients J Neurovirol 18 2012 157 161
25. LG Epstein, HE Gendelman Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms Ann Neurol 33 1993 429 436
26. NA Brabers, HS Nottet Role of the pro-inflammatory cytokines TNF-α and IL-1β in HIV-associated dementia Eur J Clin Invest 36 2006 447 458
27. BD Sippy, FM Hofman, D Wallach et al. Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS J Acquir Immune Defic Syndr Hum Retrovirol 10 1995 511 521